Search Results - Richard D. Wasnich

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density

    Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density by Richard D. Wasnich, Paul D. Miller

    Published 2000
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The effect of long-distance running upon appendicular bone mineral content

    The effect of long-distance running upon appendicular bone mineral content by JUDITH ANN WILLIAMS, John J. Wagner, Richard D. Wasnich, Lance K. Heilbrun

    Published 1984
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effect of thiazide on rates of bone mineral loss: a longitudinal study.

    Effect of thiazide on rates of bone mineral loss: a longitudinal study. by Richard D. Wasnich, J. W. Davis, Philip D. Ross, John M. Vogel

    Published 1990
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men

    The Effects of Smoking on Bone Mass and the Rates of Bone Loss Among Elderly Japanese-American Men by John M. Vogel, James W. Davis, Abraham M. Y. Nomura, Richard D. Wasnich, Philip D. Ross

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents

    Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents by Marc C. Hochberg, Susan L. Greenspan, Richard D. Wasnich, Paul D. Miller, Desmond Thompson, Philip D. Ross

    Published 2002
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

    Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1 by Pernille Ravn, D. J. Hosking, Desmond Thompson, Giovanni Cizza, Richard D. Wasnich, Michael R. McClung, A.J.P. Yates, N. H. Bjarnason, Claus Christiansen

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study

    Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study by Michael R. McClung, Richard D. Wasnich, David Hosking, Claus Christiansen, Pernille Ravn, Mei Wu, Ann Marie Mantz, John Yates, Philip D. Ross, Arthur C. Santora

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

    Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age by David Hosking, Clair E.D. Chilvers, Claus Christiansen, Pernille Ravn, Richard D. Wasnich, Philip D. Ross, Michael R. McClung, Ana Balske, Desmond Thompson, Marianne Daley, A.J.P. Yates

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup>

    Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal<sup>1</sup> by Pernille Ravn, Stuart Weiss, Jose Adolfo Rodriguez-Portales, Michael R. McClung, Richard D. Wasnich, Nigel Gilchrist, Philip N. Sambrook, Ignac Fogelman, David Krupa, A.J.P. Yates, Anastasia G. Daifotis, Ghada El‐Hajj Fuleihan

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

    Effect of Risedronate on the Risk of Hip Fracture in Elderly Women by Michael R. McClung, Piet Geusens, Paul D. Miller, H Zippel, W. Bensen, Christian Roux, Silvano Adami, Ignac Fogelman, Terrence Diamond, Richard Eastell, Pierre J. Meunier, Richard D. Wasnich, Maria Greenwald, Jean‐Marc Kaufman, Charles H. Chesnut, Jean‐Yves Reginster

    Published 2001
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  11. 11
    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

    Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis by Nelson B. Watts, Steven T. Harris, Harry K. Genant, Richard D. Wasnich, Paul D. Miller, Rebecca D. Jackson, Angelo A. Licata, Philip D. Ross, Grattan C. Woodson, M. Yanover, W. Jerry Mysiw, Larry M. Kohse, MK Rao, Peter Steiger, Bradford J. Richmond, Charles H. Chesnut

    Published 1990
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: